Familial amyloid polyneuropathy (FAP) type I and the probands of “new” families: apropos of a clinical case

Authors

  • J. P. Vieira de Andrade Serviço de Medicina III do Hospital Distrital de Santarém
  • A. M. Gameiro Serviço de Medicina III do Hospital Distrital de Santarém
  • R. Paulos Serviço de Medicina III do Hospital Distrital de Santarém
  • I. Câmara Serviço de Medicina III do Hospital Distrital de Santarém
  • M. Cabrita Serviço de Medicina III do Hospital Distrital de Santarém

Keywords:

proband, sporadic case, new families, transthyretin

Abstract

Familial amyloid polyneuropathy (FAP) type I is a progressive
autosomal-dominant neurodegenerative disorder characterized
by an extracellular amyloid fibrils deposit in the conjunctive tissue,
except in the brain and hepatic parenchyma affecting the peripheral nervous system in particular. FAP type I existence showed
to be related to valine aminoacid replacement by methionine in
position 30 of the transthyretin gene (TTR V30M). Sporadic cases
of FAP TTR V30M have been described in all of the foci of this
disease. Its existence raises some interesting questions especially
on the heredity form and the possibility of genetic modifiers.
The authors report a FAP TTR V30M case, whose relatives were
not affected by the disease, reviewing the genetic epidemiology
of such condition.

Downloads

Download data is not yet available.

References

http://medicina.med.up.pt

Lobato L. Classification of Amyloidoses. Sinapse 2006; 6 (suppl 1): 68-73.

Cooutinho CA. Cardiac Involvement in Familial amyloidotic Polyneuropathy. Sinapse 2006; 6 (suppl 1): 82-98.

Sousa A. Genetic Epidemiology of Familial Amyloid Polyneuropathy. Sinapse 2006; 6 (suppl 1): 74-79.

Coelho T, Sousa A, Lourenço E, Ramalheira J. A study of 159 Portuguese patients with familial amyloidotic polyneuropathy (FAP) whose parents were both unaffected. J Med Genet 1994; 31: 293-299.

Santos M, Dias L, Esperança P. Importância de la TTR met 30 en el diagnóstico de la polineuropatía amiloidótica familiar sin antecedentes familiares. Rev NEUROL 2000; 30 (10): 929-931.

Saraiva M M. Digestive Manifestations of Familial Amyloidotic Neuropathy. Sinapse 2006; 6 (suppl 1): 110-120.

Coelho T. The Clinical Diagnosis in Familial Amyloidotic Polyneuropathy. Sinapse 2006; 6 (suppl 1): 134-138.

Soriano-Soriano C, Tornero-Esténbanes C, Navarrro-Fernández C, Jiménez-Escrich A, Díaz-Insa S, Rull-Degura S. Polineuropatía amiloidótica familiar: dos nuevos casos de presentation tardía, con numerosos familiares portadores asintomáticos. REV NEUROL 2001; 33 (5): 494-495.

Yoshinaga T, Nakazato M, Ikeda S, Ohnishi A. Homozygosity for the transthyretin Met 30 gene in three Japanese siblings with type I gamilial amyloidotic polyneuropathy. Neurology 1992; 42: 2045-2047.

Ikeda S, Nakano T, Yanagisawa N, Nakazato M, Tsukagoshi H. Asymptomatic homozygous gene carrier in a family with type I familial amyloidotic polyneuropathy. Eur Neurol 1992; 32:308-313.

Guevera C O, Barrientos N U, Flores A R, Iduáques J C. Familial amyloidotic polyneuropathy type I. Report of one case. Rev Méd Chile 2003;

:1179-1182

Additional Files

Published

2022-11-30

How to Cite

1.
Vieira de Andrade JP, Gameiro AM, Paulos R, Câmara I, Cabrita M. Familial amyloid polyneuropathy (FAP) type I and the probands of “new” families: apropos of a clinical case. RPMI [Internet]. 2022 Nov. 30 [cited 2024 Sep. 7];18(3):159-63. Available from: https://revista.spmi.pt/index.php/rpmi/article/view/1328

Issue

Section

Case Reports